Bai, Z.; Xu, M.; Mei, Y.; Hu, T.; Zhang, P.; Chen, M.; Lv, W.; Lu, C.; Tan, S.
Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia. Biomedicines 2021, 9, 1783.
https://doi.org/10.3390/biomedicines9121783
AMA Style
Bai Z, Xu M, Mei Y, Hu T, Zhang P, Chen M, Lv W, Lu C, Tan S.
Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia. Biomedicines. 2021; 9(12):1783.
https://doi.org/10.3390/biomedicines9121783
Chicago/Turabian Style
Bai, Zhengli, Menglong Xu, Ying Mei, Tuo Hu, Panpan Zhang, Manman Chen, Wenxiu Lv, Chenchen Lu, and Shuhua Tan.
2021. "Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia" Biomedicines 9, no. 12: 1783.
https://doi.org/10.3390/biomedicines9121783
APA Style
Bai, Z., Xu, M., Mei, Y., Hu, T., Zhang, P., Chen, M., Lv, W., Lu, C., & Tan, S.
(2021). Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia. Biomedicines, 9(12), 1783.
https://doi.org/10.3390/biomedicines9121783
